デフォルト表紙
市場調査レポート
商品コード
1589532

直接飼料化微生物市場:タイプ、形態、家畜別-2025-2030年の世界予測

Direct-fed Microbials Market by Type (Bacillus subtilis, Lactic Acid Bacteria), Form (Dry, Liquid), Livestock - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 182 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
直接飼料化微生物市場:タイプ、形態、家畜別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

直接飼料化微生物市場は、2023年に12億9,000万米ドルと評価され、2024年には13億9,000万米ドルに達すると予測され、CAGR 8.10%で成長し、2030年には22億3,000万米ドルになると予測されています。

直接飼料化微生物(DFM)は、しばしばプロバイオティクスと呼ばれ、腸内健康を改善し、パフォーマンスを高め、免疫システムを強化するために家畜に投与される生きた微生物です。DFMの主な用途は、飼料効率と栄養吸収の改善、ストレス時の家畜の補助、抗生物質の代替としての役割などです。DFMの必要性は、抗生物質不使用の畜産物に対する消費者の需要の増加、抗生物質耐性に対する懸念、持続可能な農業の推進から生じています。DFMsの用途は、家禽、豚、牛、水産養殖など、家畜全般にわたっています。これらの製品は、成長率の向上、飼料要求率の改善、家畜全体の健康増進に役立ち、最終用途に大きな利益をもたらします。DFMs市場に影響を与える主な成長要因としては、世界の食肉消費量の増加、動物の健康に関する意識の高まり、農業における抗生物質使用量の削減を支持する規制支援などが挙げられます。最近のビジネスチャンスは、生物種に特化した微生物製剤の開発や、DFMとその他の飼料添加物を組み合わせて使用することで、そのメリットを最大限に引き出すことにあります。しかし、開発コストの高さ、保管や給餌プロセスを通じて微生物の生存率を維持すること、地域によって規制の枠組みが異なることなどの課題が、市場開拓の妨げとなる可能性があります。また、従来の飼料添加物に対するDFMの直接的なメリットに関する消費者の認識不足という限界もあります。こうした課題にもかかわらず、菌株の発見、送達メカニズムの強化、高度なバイオテクノロジー手法の導入における技術革新は、事業の成長を約束するものです。さまざまな家畜種における腸内細菌叢の相互作用の理解に重点を置いた研究への投資は、大きな競争優位性をもたらす可能性があります。市場の性質はダイナミックで進化しており、技術の進歩と、より健康的で抗生物質不使用の畜産物を求める消費者の需要によって形成されているため、戦略的投資とイノベーションの機は熟しています。

主な市場の統計
基準年[2023] 12億9,000万米ドル
予測年[2024] 13億9,000万米ドル
予測年[2030] 22億3,000万米ドル
CAGR(%) 8.10%

市場力学:急速に進化する直接飼料化微生物市場の主要市場インサイトを公開

直接飼料化微生物市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 動物の健康に対する意識の急速な高まりと動物性タンパク質への需要
    • 世界の食肉・牛乳消費量の増加
    • 高品質の動物製品に対する需要の増加
  • 市場抑制要因
    • 生産・運営コストの増加
  • 市場機会
    • 抗生物質成長促進剤(AGP)の使用禁止
    • 動物の健康に対する懸念の高まりによる、家畜の健康上の利点に対する認識
  • 市場の課題
    • 食品および飼料中のバクテリアの消費に関する規制のばらつき

ポーターの5つの力:直接飼料化微生物市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:直接飼料化微生物市場における外部からの影響の把握

外部マクロ環境要因は、直接飼料化微生物市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析直接飼料化微生物市場における競合情勢の把握

直接飼料化微生物市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス直接飼料化微生物市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、直接飼料化微生物市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨直接飼料化微生物市場における成功への道筋を描く

直接飼料化微生物市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 動物の健康に関する意識と動物性タンパク質の需要が急速に高まっている
      • 世界中で肉と牛乳の消費が増加
      • 高品質の動物製品に対する需要の増加
    • 抑制要因
      • 生産コストと運用コストの増加
    • 機会
      • 抗生物質成長促進剤(AGP)の使用禁止
      • 動物の健康に対する懸念の高まりによる家畜の健康上の利点への認識
    • 課題
      • 食品や飼料中の細菌の摂取に関するさまざまな規制
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 直接飼料化微生物市場:タイプ別

  • 枯草菌
    • ビフィズス菌
    • 乳酸菌
    • ストレプトコッカス・サーモフィルス
  • 乳酸菌

第7章 直接飼料化微生物市場:形態別

  • ドライ
  • 液体

第8章 直接飼料化微生物市場家畜別

  • 水生動物
  • 家禽
  • 反芻動物

第9章 南北アメリカの直接飼料化微生物市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の直接飼料化微生物市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの直接飼料化微生物市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Adisseo France SAS
  • Alltech Inc.
  • American Biosystems, Inc.
  • Animix LLC
  • BASF SE
  • Chr. Hansen Holding A/S
  • Evonik Industries AG
  • Lallemand Inc.
  • Novozymes A/S
  • Novus International, Inc.
  • Nutraferma, Inc.
  • Phibro Animal Health Corporation
  • ProviCo Pty Ltd.
  • Strong Microbials
  • The Fertrell Company
図表

LIST OF FIGURES

  • FIGURE 1. DIRECT-FED MICROBIALS MARKET RESEARCH PROCESS
  • FIGURE 2. DIRECT-FED MICROBIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DIRECT-FED MICROBIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DIRECT-FED MICROBIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DIRECT-FED MICROBIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DIRECT-FED MICROBIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIRECT-FED MICROBIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIRECT-FED MICROBIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY BIFIDOBACTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY LACTOBACILLI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY STREPTOCOCCUS THERMOPHILUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY LACTIC ACID BACTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY DRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIRECT-FED MICROBIALS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DIRECT-FED MICROBIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DIRECT-FED MICROBIALS MARKET SIZE, BY BACILLUS SUBTILIS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 190. DIRECT-FED MICROBIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. DIRECT-FED MICROBIALS MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-431752EA4B82

The Direct-fed Microbials Market was valued at USD 1.29 billion in 2023, expected to reach USD 1.39 billion in 2024, and is projected to grow at a CAGR of 8.10%, to USD 2.23 billion by 2030.

Direct-fed microbials (DFMs), often referred to as probiotics, are live microorganisms that are administered to livestock to improve gut health, enhance performance, and bolster the immune system. The primary scope of DFMs involves their role in improving feed efficiency and nutrient absorption, aiding livestock during stress, and serving as an alternative to antibiotics. The necessity of DFMs arises from increasing consumer demand for antibiotic-free animal products, concerns about antibiotic resistance, and the push for sustainable agricultural practices. Applications of DFMs span across a range of livestock such as poultry, swine, cattle, and aquaculture. These products help enhance growth rates, improve feed conversion ratios, and promote overall animal health, offering substantial end-use benefits. Key growth factors influencing the DFMs market include rising meat consumption globally, growing awareness regarding animal health, and regulatory support favoring reduced antibiotic usage in farming. Recent opportunities lie in the development of species-specific microbial formulations and the combined use of DFMs with other feed additives to maximize benefits. However, challenges such as high costs of development, maintaining microbial viability through storage and feeding processes, and varied regulatory frameworks across regions can hinder market expansion. There is also a limitation regarding the lack of consumer awareness about the direct benefits of DFMs over traditional feed additives. Despite these challenges, innovation in strain discovery, enhanced delivery mechanisms, and the incorporation of advanced biotechnological methods hold promise for business growth. Investment in research that focuses on understanding gut microbiota interactions in different livestock species could yield significant competitive advantages. The nature of the market is dynamic and evolving, shaped by technological advancements and consumer demand for healthier, antibiotic-free animal products, making it ripe for strategic investments and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 1.29 billion
Estimated Year [2024] USD 1.39 billion
Forecast Year [2030] USD 2.23 billion
CAGR (%) 8.10%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Direct-fed Microbials Market

The Direct-fed Microbials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rapidly increasing awareness about animal health and demand for animal protein
    • Rise in meat and milk consumption worldwide
    • Increasing demand for quality animal products
  • Market Restraints
    • Increasing cost of production and operations
  • Market Opportunities
    • Prohibition on the usage of antibiotic growth promoters (AGP)
    • Awareness of health benefits for livestock due to rising animal health concerns
  • Market Challenges
    • Varying regulations about the consumption of bacteria in food and feed

Porter's Five Forces: A Strategic Tool for Navigating the Direct-fed Microbials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Direct-fed Microbials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Direct-fed Microbials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Direct-fed Microbials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Direct-fed Microbials Market

A detailed market share analysis in the Direct-fed Microbials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Direct-fed Microbials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Direct-fed Microbials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Direct-fed Microbials Market

A strategic analysis of the Direct-fed Microbials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Direct-fed Microbials Market, highlighting leading vendors and their innovative profiles. These include Adisseo France SAS, Alltech Inc., American Biosystems, Inc., Animix LLC, BASF SE, Chr. Hansen Holding A/S, Evonik Industries AG, Lallemand Inc., Novozymes A/S, Novus International, Inc., Nutraferma, Inc., Phibro Animal Health Corporation, ProviCo Pty Ltd., Strong Microbials, and The Fertrell Company.

Market Segmentation & Coverage

This research report categorizes the Direct-fed Microbials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Bacillus subtilis and Lactic Acid Bacteria. The Bacillus subtilis is further studied across Bifidobacteria, Lactobacilli, and Streptococcus Thermophilus.
  • Based on Form, market is studied across Dry and Liquid.
  • Based on Livestock, market is studied across Aquatic Animals, Poultry, Ruminants, and Swine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapidly increasing awareness about animal health and demand for animal protein
      • 5.1.1.2. Rise in meat and milk consumption worldwide
      • 5.1.1.3. Increasing demand for quality animal products
    • 5.1.2. Restraints
      • 5.1.2.1. Increasing cost of production and operations
    • 5.1.3. Opportunities
      • 5.1.3.1. Prohibition on the usage of antibiotic growth promoters (AGP)
      • 5.1.3.2. Awareness of health benefits for livestock due to rising animal health concerns
    • 5.1.4. Challenges
      • 5.1.4.1. Varying regulations about the consumption of bacteria in food and feed
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Direct-fed Microbials Market, by Type

  • 6.1. Introduction
  • 6.2. Bacillus subtilis
    • 6.2.1. Bifidobacteria
    • 6.2.2. Lactobacilli
    • 6.2.3. Streptococcus Thermophilus
  • 6.3. Lactic Acid Bacteria

7. Direct-fed Microbials Market, by Form

  • 7.1. Introduction
  • 7.2. Dry
  • 7.3. Liquid

8. Direct-fed Microbials Market, by Livestock

  • 8.1. Introduction
  • 8.2. Aquatic Animals
  • 8.3. Poultry
  • 8.4. Ruminants
  • 8.5. Swine

9. Americas Direct-fed Microbials Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Direct-fed Microbials Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Direct-fed Microbials Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adisseo France SAS
  • 2. Alltech Inc.
  • 3. American Biosystems, Inc.
  • 4. Animix LLC
  • 5. BASF SE
  • 6. Chr. Hansen Holding A/S
  • 7. Evonik Industries AG
  • 8. Lallemand Inc.
  • 9. Novozymes A/S
  • 10. Novus International, Inc.
  • 11. Nutraferma, Inc.
  • 12. Phibro Animal Health Corporation
  • 13. ProviCo Pty Ltd.
  • 14. Strong Microbials
  • 15. The Fertrell Company